AU2001249794A1 - Hemoglobinase inhibitors and methods of use - Google Patents

Hemoglobinase inhibitors and methods of use

Info

Publication number
AU2001249794A1
AU2001249794A1 AU2001249794A AU4979401A AU2001249794A1 AU 2001249794 A1 AU2001249794 A1 AU 2001249794A1 AU 2001249794 A AU2001249794 A AU 2001249794A AU 4979401 A AU4979401 A AU 4979401A AU 2001249794 A1 AU2001249794 A1 AU 2001249794A1
Authority
AU
Australia
Prior art keywords
hemoglobinase
inhibitors
methods
hemoglobinase inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001249794A
Inventor
Salman Baig
David S Peterson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Georgia Research Foundation Inc UGARF
Original Assignee
University of Georgia Research Foundation Inc UGARF
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Georgia Research Foundation Inc UGARF filed Critical University of Georgia Research Foundation Inc UGARF
Publication of AU2001249794A1 publication Critical patent/AU2001249794A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/488Aspartic endopeptidases (3.4.23), e.g. pepsin, chymosin, renin, cathepsin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
AU2001249794A 2000-04-04 2001-04-04 Hemoglobinase inhibitors and methods of use Abandoned AU2001249794A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19442600P 2000-04-04 2000-04-04
US60194426 2000-04-04
PCT/US2001/010703 WO2001074373A2 (en) 2000-04-04 2001-04-04 Hemoglobinase inhibitors and methods of use

Publications (1)

Publication Number Publication Date
AU2001249794A1 true AU2001249794A1 (en) 2001-10-15

Family

ID=22717557

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001249794A Abandoned AU2001249794A1 (en) 2000-04-04 2001-04-04 Hemoglobinase inhibitors and methods of use

Country Status (3)

Country Link
US (1) US20020022024A1 (en)
AU (1) AU2001249794A1 (en)
WO (1) WO2001074373A2 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL95711A0 (en) * 1989-09-18 1991-06-30 Synergen Inc Anticoagulant and anthelmintic proteins and methods for the production and use of the same

Also Published As

Publication number Publication date
WO2001074373A3 (en) 2002-04-04
WO2001074373A2 (en) 2001-10-11
US20020022024A1 (en) 2002-02-21

Similar Documents

Publication Publication Date Title
AU2003303128A1 (en) Inhibitors and methods of use thereof
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU6340600A (en) Telomerase inhibitors and methods of their use
AU2002314466A1 (en) Withasol and methods of use
AU2001249918A1 (en) Inhibitors of inflammation and reperfusion injury and methods of use thereof
AU2001241474A1 (en) Biosensor compositions and methods of use
GB0025782D0 (en) Use of inhibitors
AU2001244355A1 (en) Heterobiarylsulphonamides and their use as pde 7 inhibitors
EP1448218A4 (en) Beta-secretase inhibitors and methods of use
AU2002361861A1 (en) SELECTIVE 11Beta-HSD INHIBITORS AND METHODS FOR USE THEREOF
AU2002230836A1 (en) Benzylamine derivatives and their use as thrombin inhibitors
AU2001255199A1 (en) Ceramide derivatives and method of use
AU2002213346A1 (en) Osteopontin-coated surfaces and methods of use
AU2002337913A1 (en) Glycosulfopeptide inhibitors and methods of use thereof
AU1334602A (en) Osteopontin-coated surfaces and methods of use
AU2003299815A1 (en) Matriptase inhibitors and methods of use
AU2003210983A1 (en) Kinase inhibitors and methods of use thereof
AU2001255696A1 (en) Telomerase inhibitors and methods of their use
AU2002363938A1 (en) Methods and use of motoneuronotropic factors
AU2001249409A1 (en) Ricin inhibitors and methods for use thereof
HUP0204376A3 (en) Novel invertase inhibitors and methods of use
AU2001232809A1 (en) Gyrase inhibitors and uses thereof
AU2001234962A1 (en) Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof
AU2003287802A1 (en) Palpometer and methods of use thereof
AU2001261496A1 (en) Luxo-sigma54 interactions and methods of use